Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma.

Li L, Wu N, Li F, Li L, Wei L, Liu J.

Cancer Biol Med. 2019 Feb;16(1):139-146. doi: 10.20892/j.issn.2095-3941.2018.0035.

2.

Locally advanced mammary analogue secretory carcinoma of the parotid gland.

Tokuzen N, Goda H, Nakashiro K.

Int J Oral Maxillofac Surg. 2019 Jul;48(7):865-868. doi: 10.1016/j.ijom.2019.01.027. Epub 2019 Feb 15.

PMID:
30777712
3.

Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.

Skálová A, Vanecek T, Uro-Coste E, Bishop JA, Weinreb I, Thompson LDR, de Sanctis S, Schiavo-Lena M, Laco J, Badoual C, Santana Conceiçao T, Ptáková N, Baněčkova M, Miesbauerová M, Michal M.

Am J Surg Pathol. 2018 Nov;42(11):1445-1455. doi: 10.1097/PAS.0000000000001133.

PMID:
30045065
4.

The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.

Skálová A, Stenman G, Simpson RHW, Hellquist H, Slouka D, Svoboda T, Bishop JA, Hunt JL, Nibu KI, Rinaldo A, Vander Poorten V, Devaney KO, Steiner P, Ferlito A.

Am J Surg Pathol. 2018 Feb;42(2):e11-e27. doi: 10.1097/PAS.0000000000000980. Review.

PMID:
29076877
5.

Newly Described Entities in Salivary Gland Pathology.

Skálová A, Gnepp DR, Lewis JS Jr, Hunt JL, Bishop JA, Hellquist H, Rinaldo A, Vander Poorten V, Ferlito A.

Am J Surg Pathol. 2017 Aug;41(8):e33-e47. doi: 10.1097/PAS.0000000000000883. Review.

PMID:
28614209
6.

Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis.

Osako T, Takeuchi K, Horii R, Iwase T, Akiyama F.

Histopathology. 2013 Oct;63(4):509-19. doi: 10.1111/his.12172. Epub 2013 Aug 14.

PMID:
23944930
7.

Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.

Connor A, Perez-Ordoñez B, Shago M, Skálová A, Weinreb I.

Am J Surg Pathol. 2012 Jan;36(1):27-34. doi: 10.1097/PAS.0b013e318231542a.

PMID:
21989350
8.

ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.

Tognon CE, Somasiri AM, Evdokimova VE, Trigo G, Uy EE, Melnyk N, Carboni JM, Gottardis MM, Roskelley CD, Pollak M, Sorensen PH.

Cancer Res. 2011 Feb 1;71(3):1060-70. doi: 10.1158/0008-5472.CAN-10-3096. Epub 2010 Dec 9.

9.

Secretory carcinoma of the breast: a genetically defined carcinoma entity.

Diallo R, Tognon C, Knezevich SR, Sorensen P, Poremba C.

Verh Dtsch Ges Pathol. 2003;87:193-203.

PMID:
16888913
10.

STAT 5a expression in the breast is maintained in secretory carcinoma, in contrast to other histologic types.

Strauss BL, Bratthauer GL, Tavassoli FA.

Hum Pathol. 2006 May;37(5):586-92.

PMID:
16647957
11.

Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.

Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, Gelman R, Brennan C, Polyak K.

Cancer Res. 2006 Apr 15;66(8):4065-78.

12.

Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization.

Lambros MB, Simpson PT, Jones C, Natrajan R, Westbury C, Steele D, Savage K, Mackay A, Schmitt FC, Ashworth A, Reis-Filho JS.

Lab Invest. 2006 Apr;86(4):398-408.

13.

ETV6 gene rearrangements in invasive breast carcinoma.

Letessier A, Ginestier C, Charafe-Jauffret E, Cervera N, Adélaïde J, Gelsi-Boyer V, Ahomadegbe JC, Benard J, Jacquemier J, Birnbaum D, Chaffanet M.

Genes Chromosomes Cancer. 2005 Sep;44(1):103-8.

PMID:
15887243
14.

Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry.

Diallo R, Schaefer KL, Bankfalvi A, Decker T, Ruhnke M, Wülfing P, Jackisch C, Luttges J, Sorensen PH, Singh M, Poremba C.

Hum Pathol. 2003 Dec;34(12):1299-305.

PMID:
14691916
15.

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.

Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C, Sorensen PH.

Cancer Cell. 2002 Nov;2(5):367-76.

16.

ETV6-NTRK3--Trk-ing the primary event in human secretory breast cancer.

Euhus DM, Timmons CF, Tomlinson GE.

Cancer Cell. 2002 Nov;2(5):347-8. Review.

Supplemental Content

Loading ...
Support Center